Focal sharp waves are a specific early-stage marker of the MM2-cortical form of sporadic Creutzfeldt-Jakob disease.
Electroencephalogram
MM2 cortical form
focal spike-and-wave complexes
periodic sharp wave complexes
sporadic Creutzfeldt-Jakob disease
Journal
Prion
ISSN: 1933-690X
Titre abrégé: Prion
Pays: United States
ID NLM: 101472305
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
entrez:
14
8
2020
pubmed:
14
8
2020
medline:
1
10
2021
Statut:
ppublish
Résumé
Periodic sharp wave complexes (PSWCs), identified using electroencephalography, are observed in less than half of patients with the methionine homozygosity type 2 cortical (MM2c) form of sporadic Creutzfeldt-Jakob disease (sCJD), and only at a later stage of the disease. In this study, we identified early and specific markers on the electroencephalograms (EEGs) of patients with MM2c-sCJD. We retrospectively investigated the clinical records, EEGs, and magnetic resonance imaging (MRI) scans of patients diagnosed with sCJD and compared the EEG findings of MM2c-sCJD and MM1/classic sCJD groups. The records of six patients with MM2c-sCJD and eight with MM1/classic sCJD were included. The median ages of onset in the MM2c- and MM1/classic sCJD groups were 75.0 (range, 60-83) and 72.5 (range, 51-74) years, respectively, and the average durations between disease onset and the first EEG were 9.17 (range, 4-15) and 1.88 (range, 1-4) months, respectively. Focal sharp waves and/or focal spike-and-wave complexes in the brain regions corresponding with cortical hyperintensities on MRI scans were identified on the EEGs of patients with MM2c-sCJD in the early stages of disease progression. In contrast, EEGs of patients in the early stages of MM1/classic sCJD showed lateralized or generalized diffuse sharp waves and spike-and-wave complexes, which were not limited to cortical hyperintensities identified with MRI scans. Our findings indicate that focal sharp waves and/or focal spike-and-wave complexes on the EEGs of patients in the early phase of MM2c-sCJD are characteristic of the disease, suggesting the possible usefulness of this characteristic for early diagnosis.
Identifiants
pubmed: 32787547
doi: 10.1080/19336896.2020.1803516
pmc: PMC7518755
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
207-213Références
Neurology. 2002 Jan 22;58(2):192-7
pubmed: 11805244
Clin Neurol Neurosurg. 2010 Jul;112(6):537-40
pubmed: 20430517
Brain Pathol. 1998 Jul;8(3):499-513
pubmed: 9669700
SAGE Open Med Case Rep. 2017 Dec 11;5:2050313X17744482
pubmed: 29276596
Clin Neurophysiol. 2004 Nov;115(11):2467-78
pubmed: 15465434
Neurology. 2009 Apr 21;72(16):1425-31
pubmed: 19380702
Neurology. 2004 Aug 10;63(3):436-42
pubmed: 15304573
J Neurol Neurosurg Psychiatry. 2018 May;89(5):461-466
pubmed: 29142140
Dement Geriatr Cogn Disord. 2005;19(5-6):324-30
pubmed: 15785033
Arch Neurol. 1981 May;38(5):312-4
pubmed: 7013738
Arch Neurol. 2006 Jun;63(6):876-80
pubmed: 16769870
J Clin Neurophysiol. 2008 Feb;25(1):25-31
pubmed: 18303557
Prion. 2019 Jan;13(1):124-131
pubmed: 31219399
Ann Neurol. 2000 Sep;48(3):323-9
pubmed: 10976638
Ann Neurol. 1979 Feb;5(2):177-88
pubmed: 371520
Neurology. 2005 Feb 22;64(4):643-8
pubmed: 15728285
Ann Neurol. 1999 Aug;46(2):224-33
pubmed: 10443888
Clin Neurophysiol. 2004 Feb;115(2):316-9
pubmed: 14744571
Neurosurg Focus. 2015 Nov;39(5):E2
pubmed: 26646926
Neurol Sci. 2011 Aug;32(4):719-22
pubmed: 21556866
Epilepsy Behav Case Rep. 2019 Jan 26;11:77-80
pubmed: 30788213
Brain. 2009 Oct;132(Pt 10):2643-58
pubmed: 19734292
PLoS One. 2013;8(3):e60003
pubmed: 23555862
Arch Neurol. 1996 Feb;53(2):162-6
pubmed: 8639066
J Neurol Sci. 2015 Jan 15;348(1-2):274-6
pubmed: 25433451
Int J Mol Sci. 2011;12(9):6281-92
pubmed: 22016658
Biochem Biophys Res Commun. 2018 Feb 19;496(4):1055-1061
pubmed: 29382530
J Alzheimers Dis. 2015;50(2):465-76
pubmed: 26682685
J Neurol Sci. 2015 Dec 15;359(1-2):424-9
pubmed: 26478131
Brain. 2010 Oct;133(10):3043-57
pubmed: 20855418
Arch Neurol. 1980 Mar;37(3):143-5
pubmed: 6986863